These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33290747)
1. MicroRNA-139 inhibits pancreatic-cancer carcinogenesis by suppressing RalB via the Ral/RAC/PI3K pathway. Wang Y; Zheng Y; Chen Q; Dai Y; Li T Arch Biochem Biophys; 2021 Jun; 704():108719. PubMed ID: 33290747 [TBL] [Abstract][Full Text] [Related]
2. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis. Wang W; Wang J; Yang C; Wang J IUBMB Life; 2021 Jun; 73(6):866-882. PubMed ID: 33759343 [TBL] [Abstract][Full Text] [Related]
4. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Li J; You T; Jing J Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182 [TBL] [Abstract][Full Text] [Related]
5. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation. Zhu J; Lv J; Chen J; Zhang X; Ji Y Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959 [No Abstract] [Full Text] [Related]
6. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway. Abuduer M; A EZG Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521 [TBL] [Abstract][Full Text] [Related]
7. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
8. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3. Wan X; Guo D; Zhu Q; Qu R Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G309-G322. PubMed ID: 32463333 [TBL] [Abstract][Full Text] [Related]
9. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-4317 suppresses the progression of hepatocellular carcinoma by targeting ZNF436-mediated PI3K/AKT signaling pathway. Zhang L; Chang S; Zhao Y; Cao G; Zhang D Tissue Cell; 2022 Feb; 74():101696. PubMed ID: 34861581 [TBL] [Abstract][Full Text] [Related]
11. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494 [TBL] [Abstract][Full Text] [Related]
12. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. Xu S; Ge J; Zhang Z; Zhou W Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829 [TBL] [Abstract][Full Text] [Related]
13. miR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation, migration, invasion and pathological angiogenesis via PI3K-Akt pathway. Liang L; Gao C; Li Y; Sun M; Xu J; Li H; Jia L; Zhao Y Cell Death Dis; 2017 Aug; 8(8):e2968. PubMed ID: 28771224 [TBL] [Abstract][Full Text] [Related]
14. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway. Liu GL; Yang HJ; Liu B; Liu T J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459 [TBL] [Abstract][Full Text] [Related]
15. MiR-19 enhances pancreatic cancer progression by targeting PTEN through PI3K/AKT signaling pathway. Zhang GF; Zhong JM; Lin L; Liu ZH Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1098-1107. PubMed ID: 32096172 [TBL] [Abstract][Full Text] [Related]
16. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway. Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444 [TBL] [Abstract][Full Text] [Related]
17. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Ye F; Tian L; Zhou Q; Feng D Gene; 2019 Dec; 721():144093. PubMed ID: 31473323 [TBL] [Abstract][Full Text] [Related]
18. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells. Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway. Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526 [TBL] [Abstract][Full Text] [Related]
20. MiR-1246 regulates the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth. Li J; Zhang Z; Hu J; Wan X; Huang W; Zhang H; Jiang N Mol Cell Biochem; 2022 Mar; 477(3):649-661. PubMed ID: 34870753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]